Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD

• Nathalie Busso ,

  Contributed equally to this work with: Nathalie Busso, Mahir Karababa

  Affiliation Service of Rheumatology, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland

  ⨯
• Mahir Karababa ,

  Contributed equally to this work with: Nathalie Busso, Mahir Karababa

  Affiliation Service of Rheumatology, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland

  ⨯
• Massimo Nobile,

  Affiliation TopoTarget Switzerland SA, Lausanne, Switzerland

  ⨯
• Aline Rolaz,

  Affiliation TopoTarget Switzerland SA, Lausanne, Switzerland

  ⨯
• Frédéric Van Gool,

  Affiliation Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Gosselies, Belgium

  ⨯
• Mara Galli,

  Affiliation Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Gosselies, Belgium

  ⨯
• Oberdan Leo,

  Affiliation Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Gosselies, Belgium

  ⨯
• Alexander So,

  Affiliation Service of Rheumatology, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland

  ⨯
• Thibaut De Smedt

  * E-mail: desmedtt@mac.com

  Affiliation TopoTarget Switzerland SA, Lausanne, Switzerland

  ⨯